跳到主要內容

Summer Road LLC 的 Form 4 申報

Ocular Therapeutix, Inc(OCUL),2022/1/24 申報

申報編號
0001567619-22-001593
申報時間
2022/1/24
交易日
2022/1/20-1/24
申報延遲
4 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 3 筆非衍生性交易。公開市場買進合計 $40.6 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Summer Road LLCCIK 0001604873持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/1/20Common Stock, $0.0001 par value per shareP買進取得+17,948$5.70F4+$102,303.65,832,709間接
2022/1/21Common Stock, $0.0001 par value per shareP買進取得+12,152$5.56F5+$67,565.125,844,861間接
2022/1/24Common Stock, $0.0001 par value per shareP買進取得+44,400$5.31F6+$235,7645,889,261間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F4

Represents the weighted average set forth in this line item. On January 20, 2022, the Reporting Person acquired 17,948 shares of Common Stock at a weighted average price of $5.7045 (ranging from a low of $5.64 and a high of $6.06). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents the weighted average set forth in this line item. On January 21, 2022, the Reporting Person acquired 12,152 shares of Common Stock at a weighted average price of $5.5572 (ranging from a low of $5.45 and a high of $5.68). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents the weighted average set forth in this line item. On January 24, 2022, the Reporting Person acquired 44,400 shares of Common Stock at a weighted average price of $5.3129 (ranging from a low of $5.18 and a high of $5.68). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)